Regeneron Pharmaceuticals, Inc.
Regeneron is a leading biotechnology company dedicated to using science to develop and deliver innovative medicines for serious diseases. With a focus on genetics, biology, and technology, the company aims to transform science into medicine through proprietary technologies like VelociSuite and collaborations such as the Regeneron Genetics Center. Its mission emphasizes relentless innovation, responsible business practices, and improving human health worldwide.
Industries
Nr. of Employees
Very Large (1000+)
Regeneron Pharmaceuticals, Inc.
Products
Clinical and commercial biologic medicines
Biologic therapeutic products developed via antibody discovery platforms and manufactured for clinical and commercial use across multiple therapeutic areas.
Investigational genetic medicine candidates
Gene therapy, gene editing and oligonucleotide therapeutic candidates under research and clinical development for central nervous system and other indications.
Bispecific antibody therapeutic candidates
Engineered bispecific antibodies designed to engage two targets with formats developed for manufacturability and clinical evaluation.
Population-scale genomic resources and variant browsers
Publicly accessible summary variant data and web-based variant browsers derived from large sequencing projects to support external research.
Clinical development pipeline (investigational candidates)
A portfolio of investigational candidates in clinical development across multiple therapeutic areas.
Clinical and commercial biologic medicines
Biologic therapeutic products developed via antibody discovery platforms and manufactured for clinical and commercial use across multiple therapeutic areas.
Investigational genetic medicine candidates
Gene therapy, gene editing and oligonucleotide therapeutic candidates under research and clinical development for central nervous system and other indications.
Bispecific antibody therapeutic candidates
Engineered bispecific antibodies designed to engage two targets with formats developed for manufacturability and clinical evaluation.
Population-scale genomic resources and variant browsers
Publicly accessible summary variant data and web-based variant browsers derived from large sequencing projects to support external research.
Clinical development pipeline (investigational candidates)
A portfolio of investigational candidates in clinical development across multiple therapeutic areas.
Services
Managed access program for investigational medicines
Framework to provide certain patients access to investigational therapies when no satisfactory alternatives or trials are available.
Patient support and assistance programs
Programs providing education, insurance eligibility support, financial assistance and donated medicine to eligible patients.
Global medical information and adverse event reporting
Centralized medical information contact and procedures for reporting adverse events and product complaints.
Collaborative sequencing and data-sharing partnerships
Partnerships with biobanks, health systems and research consortia to conduct sequencing, proteomics and analytic projects at population scale.
Employee giving and matching gift program
Corporate matching of eligible employee donations to qualified public charities to increase the impact of employee philanthropy.
Employee volunteer program coordination
Organization of volunteer opportunities including global weeks of service and locally coordinated volunteer events supported by regional employee councils.
Managed access program for investigational medicines
Framework to provide certain patients access to investigational therapies when no satisfactory alternatives or trials are available.
Patient support and assistance programs
Programs providing education, insurance eligibility support, financial assistance and donated medicine to eligible patients.
Global medical information and adverse event reporting
Centralized medical information contact and procedures for reporting adverse events and product complaints.
Collaborative sequencing and data-sharing partnerships
Partnerships with biobanks, health systems and research consortia to conduct sequencing, proteomics and analytic projects at population scale.
Employee giving and matching gift program
Corporate matching of eligible employee donations to qualified public charities to increase the impact of employee philanthropy.
Employee volunteer program coordination
Organization of volunteer opportunities including global weeks of service and locally coordinated volunteer events supported by regional employee councils.
Expertise Areas
- Population-scale genomics and genetic discovery
- Antibody discovery, engineering and bispecific development
- Biologics manufacturing and supply operations
- Genetic medicines development (gene therapy, gene editing, oligonucleotides)
Key Technologies
- Exome sequencing
- Genotyping and imputation analysis
- Population-scale proteomics
- Engineered mouse models for target validation